Highlights of this issue
Cannabis and health†
Amitriptyline: still efficacious, but at what cost?†
Pharmacology and effects of cannabis: a brief review†
Therapeutic aspects of cannabis and cannabinoids†
Psychiatric effects of cannabis†
Evaluating alternative cannabis regimes*†
Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials†
Prevalence, comorbidity, disability and service utilisation
Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community†
Invited commentary on: Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community†
Comparison of the outcome and treatment of psychosis in people of Caribbean origin living in the UK and British Whites
Intellectual functioning and outcome of patients with severe psychotic illness randomised to intensive case management
Cerebral white matter lesions in bipolar affective disorder: relationship to outcome
Concerns over confidentiality
Whose consent is it anyway?
Evolution and psychiatry
Evolution and psychiatry
Evolution and psychiatry
Evolution and psychiatry
Psychotropic drugs and sudden death
Cognitive-behavioural techniques in practice
Cognitive-behavioural techniques in practice
Assessing quality of life in schizophrenia
Assessing quality of life in schizophrenia
Is couple therapy better than antidepressant drugs?
Is couple therapy better than antidepressant drugs?
Citalopram-induced bruxism
Psychological debriefing - does it never work?
Diazepam in the treatment of GHB dependence
Seasonality of suicides
Seasonality of suicides
Remember the depressed vegetarian
London County Asylum, Claybury, Essex (Annual Report for 1899)
The Mental Health Matrix: A Manual to Improve Services
Violence: Reflections on Our Deadliest Epidemic
Ethical Practice and the Abuse of Power in Social Responsibility: Leave No Stone Unturned
Statistics in Psychiatry